These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9828974)

  • 41. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.
    Wood E; Tyndall MW; Spittal PM; Li K; Hogg RS; Montaner JS; O'Shaughnessy MV; Schechter MT
    AIDS; 2002 Apr; 16(6):941-3. PubMed ID: 11919503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.
    Small W; Kain S; Laliberte N; Schechter MT; O'Shaughnessy MV; Spittal PM
    Subst Use Misuse; 2005; 40(6):831-43. PubMed ID: 15974143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response.
    Miller CL; Spittal PM; Frankish JC; Li K; Schechter MT; Wood E
    Can J Public Health; 2005; 96(2):107-8. PubMed ID: 15850028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV incidence and associated risk factors among young injection drug users.
    Miller CL; Tyndall M; Spittal P; Li K; LaLiberte N; Schechter MT
    AIDS; 2002 Feb; 16(3):491-3. PubMed ID: 11834965
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug and HIV-related risk behaviors after geographic migration among a cohort of injection drug users.
    Rachlis BS; Wood E; Li K; Hogg RS; Kerr T
    AIDS Behav; 2010 Aug; 14(4):854-61. PubMed ID: 18427970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thailand ignores HIV epidemic in drug users.
    Walgate R
    BMJ; 2004 Jul; 329(7458):127. PubMed ID: 15258049
    [No Abstract]   [Full Text] [Related]  

  • 47. Holding the lid on HIV.
    Anderson JF
    Can J Public Health; 1999; 90(5):296-8. PubMed ID: 10570569
    [No Abstract]   [Full Text] [Related]  

  • 48. Vancouver's supervised injection facility challenges Canada's drug laws.
    Dooling K; Rachlis M
    CMAJ; 2010 Sep; 182(13):1440-4. PubMed ID: 20805208
    [No Abstract]   [Full Text] [Related]  

  • 49. British Columbia: studies show positive public impacts of harm-reduction measures for drug users.
    Betteridge G
    HIV AIDS Policy Law Rev; 2004 Dec; 9(3):27. PubMed ID: 15801109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of income assistance payment and overdose patterns at a Canadian supervised injection facility.
    Zlotorzynska M; Milloy MJ; Richardson L; Nguyen P; Montaner JS; Wood E; Kerr T
    Int J Drug Policy; 2014 Jul; 25(4):736-9. PubMed ID: 24795288
    [No Abstract]   [Full Text] [Related]  

  • 51. A qualitative investigation of antiretroviral therapy among injection drug users.
    Pach A; Cerbone FG; Gerstein DR
    AIDS Behav; 2003 Mar; 7(1):87-100. PubMed ID: 14534393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent lack of human immunodeficiency virus infection in intravenous drug users at very high risk.
    Boiocchi M; Franceschi S; Serraino D; Guarneri S; Tavian M; Diodato S
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):633-5. PubMed ID: 8496794
    [No Abstract]   [Full Text] [Related]  

  • 53. Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.
    O'Shaughnessy MV; Hogg RS; Strathdee SA; Montaner JS
    Curr HIV/AIDS Rep; 2012 Dec; 9(4):394-400. PubMed ID: 22773331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasing prevalence of cocaine as the primary detoxification diagnosis among admissions presenting with current intravenous drug use: a review of detoxification records from northern British Columbia, 1999-2005.
    Callaghan RC; Strike C; Kerr T; Fischer B; Buxton J; Stevens E; Taylor L; Victor JC
    Can J Public Health; 2008; 99(3):178-81. PubMed ID: 18615936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Letter to the editor: HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report.
    Salminen M
    Euro Surveill; 2011 Oct; 16(41):author reply pii: 19987. PubMed ID: 22008202
    [No Abstract]   [Full Text] [Related]  

  • 56. Investigation of Human Immunodeficiency Virus Outbreaks Among People Who Inject Drugs: Timely Diagnosis and Molecular Surveillance are Crucial.
    Paraskevis D
    J Infect Dis; 2017 Nov; 216(9):1049-1050. PubMed ID: 29029266
    [No Abstract]   [Full Text] [Related]  

  • 57. First evaluation of Vancouver safe injection facility.
    Betteridge G
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):20, 22. PubMed ID: 16365963
    [No Abstract]   [Full Text] [Related]  

  • 58. Vancouver safe injection facility: more positive results.
    Betteridge G
    HIV AIDS Policy Law Rev; 2006 Apr; 11(1):19-20. PubMed ID: 16805008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study shows Aboriginals who inject drugs are at higher risk for HIV.
    Thomas K
    Can HIV AIDS Policy Law Rev; 2003 Apr; 8(1):26. PubMed ID: 12924294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous drug use and hepatitis A: an investigation of an outbreak.
    Jin A; Bardsley J
    Can J Public Health; 1990; 81(1):79-81. PubMed ID: 2311058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.